Physician profile
Roy B Roberts
NPI 1467434159
$965.19
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $267 · 2021: $215 · 2022: $138 · 2023: $203 · 2024: $17.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $272.76 | 2019-2023 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $163.39 | 2019-2023 | |
| Astellas Pharma US INC | $75.57 | 2020-2021 | |
| Pfizer INC. | $55.94 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $45.41 | 2019-2023 | Livalo |
| Ibsa Pharma INC. | $40.34 | 2020-2021 | |
| Lilly USA, LLC | $36.52 | 2022-2023 | Mounjaro |
| Abbott Laboratories | $34.17 | 2023-2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $25.42 | 2021-2022 | |
| Eisai INC. | $22.83 | 2019 | |
| Glaxosmithkline, LLC. | $21.16 | 2023 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $18.59 | 2021 | |
| Esperion Therapeutics, INC. | $18.34 | 2021 | |
| Seqirus USA INC | $16.74 | 2020 | |
| Medtronic, INC. | $16.38 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.98 | 2021 | |
| Adlon Therapeutics L.P. | $15.97 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.65 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.14 | 2019 | |
| Currax Pharmaceuticals LLC | $13.90 | 2022 | |
| Boston Scientific Corporation | $13.33 | 2019 | |
| Vivus LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.